Hertfordshire, UK – [07.10.2024] – PHARMExcel, a leading specialist in NHS and Biotech clinical trial support, is proud to announce its nomination as a finalist for the prestigious SCRIP Awards 2024. Celebrating its 20th anniversary, the SCRIP Awards is renowned for recognising excellence in the global biopharmaceutical industry, and PHARMExcel’s nomination in the “Best Contract Research Organisation – Specialist Providers” category highlights its exceptional contributions to clinical research.
This recognition places PHARMExcel alongside the finest in the industry, acknowledging the critical role specialist CROs play in advancing drug development. The SCRIP Awards Judging Panel, comprised of esteemed experts from across the globe, will meticulously evaluate finalists based on the quality of their services and the strong relationships they maintain with their clients.
Competing in the Best Contract Research Organisation – Specialist Providers category, PHARMExcel joins an elite group of companies recognised for their outstanding contributions to clinical research and the global biopharmaceutical industry.
This year’s finalists amongst PHARMExcel include:
As a boutique CRO, PHARMExcel has been a trusted partner in delivering a ‘mix and match’ service model tailored to the specific needs of its clients within the NHS, Academia and Spin Outs. This nomination reinforces the company’s commitment to innovation, quality, and excellence in clinical research.
The winners will be announced at the 20th SCRIP Awards gala on Wednesday, 4 December 2024, at the iconic Raffles London at The OWO, a newly restored venue set to host over 400 industry leaders for an evening of celebration, networking, and recognition.
“We are honoured to be nominated for such a prestigious award,” said Yvanne Enever, CEO at PHARMExcel. “This nomination is a testament to the dedication of our entire team, and we are grateful for the continued trust and partnership of our clients.”
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) that genuinely delivers a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Tel: +44 (0) 2036426654
Email: info@pharmexcel-cro.uk
